Clinical Trial Update: Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD [Phase 3]

View source ↗

Summary

A Phase 3, placebo-controlled, double-blind trial in adults with ADHD evaluating extended-release methylphenidate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate ER (methylphenidate extended-release)

Snippet

Sponsor: Medice Arzneimittel Pütter GmbH & Co KG | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED